Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1994-06-07

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1073/PNAS.91.12.5562PMID 8202528PMCID PMC44036
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alzheimer paired helical filaments: Immunochemical identification of polypeptides

  2004cited by this paper
• Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease.

  1993cited by this paper
• Differences in microtubule binding and self-association abilities of bovine brain tau isoforms.

  1993cited by this paper
• Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding.

  1993cited by this paper
• Brain Levels of Microtubule‐Associated Protein τ Are Elevated in Alzheimer's Disease: A Radioimmuno‐Slot‐Blot Assay for Nanograms of the Protein

  1992cited by this paper
• The microtubule-associated protein tau forms a triple-stranded left-hand helical polymer.

  1991cited by this paper
• Detection of tubulin-binding proteins by an overlay assay.

  1988cited by this paper
• Microtubule-associated polypeptides tau are altered in Alzheimer paired helical filaments.

  1988cited by this paper
• Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.

  1986cited by this paper
• Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

  1986cited by this paper
• Defective brain microtubule assembly in Alzheimer's disease.

  1986cited by this paper
• The distribution of tau in the mammalian central nervous system

  1985cited by this paper
• Phosphorylation affects the ability of tau protein to promote microtubule assembly.

  1984cited by this paper
• Ultrastructure of Paired Helical Filaments of Alzheimer's Neurofibrillary Tangle

  1984cited by this paper
• Decoration and stabilization of intact, smooth-walled microtubules with microtubule-associated proteins.

  1979cited by this paper
• Assay of proteins in the presence of interfering materials.

  1976cited by this paper
• Microtubule assembly in the absence of added nucleotides.

  1973cited by this paper
• ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S PRESENILE DEMENTIA.

  1964cited by this paper

• Biophysically realistic network-level transport model of tau progression with exosome-mediated release and uptake processes

  2026cites this paper
• Investigating the Single-Fibril Growth Dynamics of Tau in a Heterogeneous Aggregation Landscape.

  2026cites this paper
• Polyamination with spermidine enhances pathogenic tau conformations while reducing filamentous aggregate formation in vitro

  2025cites this paper
• Unraveling APOE4: The dual role in CNS and peripheral inflammation in Alzheimer's disease.

  2025cites this paper
• Intrinsically Disordered Peptide Nanofibers from a Structured Motif Within Proteins

  2025cites this paper
• O-GlcNAc modification differentially regulates microtubule binding and pathological conformations of tau isoforms in vitro

  2025cites this paper
• Cellular and molecular mechanisms of pathological tau phosphorylation in traumatic brain injury: implications for chronic traumatic encephalopathy

  2025cites this paper
• Cross-Talk Between Tau O-GlcNAcylation and the Formation of the Early Driver of Neurodegeneration (Cis P-Thr231-Pro Tau) in Primary Cortical Neurons

  2025cites this paper
• Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons

  2025cites this paper
• Lithium mitigates hippocampal tau pathology in a rodent model of traumatic brain injury

  2025cites this paper
• Effect of PHF-1 hyperphosphorylation on the seeding activity of C-terminal Tau fragments

  2025cites this paper
• Homeostatic Activation of 26S Proteasomes by Protein Kinase A Protects against Cardiac and Neurobehavior Malfunction in Alzheimer’s Disease Mice

  2025cites this paper
• Analysis of phosphorylation site occupancy of peptides based on a chemical derivatization method.

  2025cites this paper
• Stabilizing microtubules increases acute cellular injury at high strain rates.

  2025cites this paper
• Tau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities

  2025cites this paper
• Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein

  2025cites this paper
• A novel pThr217 tau monoclonal antibody reveals neuropathological heterogeneity in tauopathies

  2025cites this paper
• Targeted tau protein degradation: a promising therapeutic approach for tauopathies.

  2025cites this paper
• Protein Phosphatase 5-Recruiting Chimeras for Accelerating Tau Dephosphorylation.

  2025cites this paper
• Updates in Alzheimer's disease: from basic research to diagnosis and therapies

  2024cites this paper
• Phosphorylation of tau protein based on the activity of kinases and phosphatases in various forms of synaptic plasticity.

  2024cites this paper
• Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes.

  2024cites this paper
• Neuropathogenesis-on-chips for neurodegenerative diseases

  2024cites this paper
• An Overview of the Genes and Biomarkers in Alzheimer's Disease.

  2024cites this paper
• Therapeutic potential of saffron in brain disorders: From bench to bedside

  2024cites this paper
• A small‐molecule microtubule‐stabilizing agent safely reduces Aβ plaque and tau pathology in transgenic mouse models of Alzheimer's disease

  2024cites this paper
• Proteomic Analysis of a Rat Streptozotocin Model Shows Dysregulated Biological Pathways Implicated in Alzheimer’s Disease

  2024cites this paper
• Phosphorylation of Tau Protein by CDK2/cyclin A and GSK3β Recombinant Kinases: Analysis of Phosphorylation Patterns by Nuclear Magnetic Resonance Spectroscopy.

  2024cites this paper
• Potential Therapeutic Effects of Bifidobacterium breve MCC1274 on Alzheimer’s Disease Pathologies in AppNL-G-F Mice

  2024cites this paper
• Nanomodulators That Target Alzheimer’s Disease: A Review

  2024cites this paper
• Spatial differences in gene expression across the dorsal raphe nucleus in a model of early Alzheimer's disease

  2024cites this paper
• The phospho-tau cascade, basal forebrain neurodegeneration, and dementia in Alzheimer's disease: Anti-neurodegenerative benefits of acetylcholinesterase inhibitors

  2024cites this paper
• The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges

  2024cites this paper
• Role of Human Serum Albumin in the Prevention and Treatment of Alzheimer’s Disease

  2024cites this paper
• Tau induces inflammasome activation and microgliosis through acetylating NLRP3

  2024cites this paper
• Tau‐targeting nanoparticles for treatment of Alzheimer's disease

  2024cites this paper
• Intracellular Tau Fragment Droplets Serve as Seeds for Tau Fibrils

  2024cites this paper
• A pentavalent peptide vaccine elicits Aβ and tau antibodies with prophylactic activity in an Alzheimer's disease mouse model.

  2024cites this paper
• A network-level transport model of tau progression in the Alzheimer's brain.

  2024cites this paper
• Tau-S214 phosphorylation inhibits Fyn kinase interaction and increases the decay time of NMDAR-mediated current.

  2024cites this paper
• Electrophysiological Insights into Alzheimer's Disease: A Review of Human and Animal Studies.

  2024cites this paper
• Real-Time Tracking of Vesicles in Living Cells Reveals That Tau-Hyperphosphorylation Suppresses Unidirectional Transport by Motor Proteins

  2024cites this paper
• PM2.5 triggers tau aggregation in a mouse model of tauopathy

  2024cites this paper
• Tau Protein Alterations Induced by Hypobaric Hypoxia Exposure

  2024influential citation
• Long-Term High-Fat Diet Consumption Induces Cognitive Decline Accompanied by Tau Hyper-Phosphorylation and Microglial Activation in Aging

  2023cites this paper
• Simufilam Reverses Aberrant Receptor Interactions of Filamin A in Alzheimer’s Disease

  2023cites this paper
• Friends and Foes in Alzheimer’s Disease

  2023cites this paper
• STAT3 ameliorates truncated tau-induced cognitive deficits

  2023cites this paper
• Active constituents of saffron (Crocus sativus L.) and their prospects in treating neurodegenerative diseases (Review)

  2023cites this paper
• Increased G3BP2-Tau interaction in tauopathies is a natural defense against Tau aggregation.

  2023cites this paper
• Targeting α7 nicotinic acetylcholine receptors and their protein interactions in Alzheimer's disease drug development

  2023cites this paper
• Alzheimer’s disease: a mini-review for the clinician

  2023cites this paper
• Evaluation of N- and O-Linked Indole Triazines for a Dual Effect on α-Synuclein and Tau Aggregation

  2023cites this paper
• Highly Specialized Mechanisms for Mitochondrial Transport in Neurons: From Intracellular Mobility to Intercellular Transfer of Mitochondria

  2023cites this paper
• Two simple assays for assessing the seeding activity of proteopathic tau

  2023cites this paper
• The role of human serum albumin in prevention and treatment of Alzheimer’s disease

  2023cites this paper
• The Adult Neurogenesis Theory of Alzheimer’s Disease

  2023cites this paper
• Pathological and physiological functional cross-talks of α-synuclein and tau in the central nervous system

  2023cites this paper
• Fluorescent Sensing Platforms for Detecting and Imaging the Biomarkers of Alzheimer’s Disease

  2023cites this paper
• Implications of Tau Dysregulation in Huntington’s Disease and Potential for New Therapeutics

  2023cites this paper
• Insulin and Disorders of Behavioural Flexibility.

  2023cites this paper
• Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer’s Disease

  2023cites this paper
• Friend or foe: role of pathological tau in neuronal death.

  2023cites this paper
• Atomistic Insights into the Inhibitory Mechanism of Tyrosine Phosphorylation against the Aggregation of Human Tau Fragment PHF6.

  2023cites this paper
• Hyperphosphorylated tau Inflicts Intracellular Stress Responses That Are Mitigated by Apomorphine

  2023cites this paper
• AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer's disease.

  2023cites this paper
• Microtubule Cytoskeletal Network Alterations in a Transgenic Model of Tuberous Sclerosis Complex: Relevance to Autism Spectrum Disorders

  2023cites this paper
• Tau and Alzheimer's disease: Past, present and future

  2023cites this paper
• Polymerization of recombinant tau core fragments in vitro and seeding studies in cultured cells

  2023cites this paper
• The HSP40 family chaperone isoform DNAJB6b prevents neuronal cells from tau aggregation

  2023cites this paper
• Chronic Sustained Hypoxia Leads to Brainstem Tauopathy and Declines the Power of Rhythms in the Ventrolateral Medulla: Shedding Light on a Possible Mechanism

  2023cites this paper
• Dysregulation of mTOR by tau in Alzheimer's disease

  2023cites this paper
• P25/CDK5-mediated Tau Hyperphosphorylation in Both Ipsilateral and Contralateral Cerebra Contributes to Cognitive Deficits in Post-stroke Mice

  2023cites this paper
• How do neurons age? A focused review on the aging of the microtubular cytoskeleton

  2023cites this paper
• The role of positively charged small biomolecules in the aggregation of hyperphosphorylated tau in Alzheimer’s disease

  2023cites this paper
• Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer’s disease? From preclinical studies to the clinical trials

  2023cites this paper
• Mechanisms of the Beneficial Effects of Exercise on Brain-Derived Neurotrophic Factor Expression in Alzheimer’s Disease

  2023cites this paper
• Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease

  2023cites this paper
• Hyperphosphorylated Tau Inflicts Intracellular Stress Responses that Are Mitigated by Apomorphine

  2023cites this paper
• Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer’s Disease

  2022cites this paper
• Tau protein misfolding and aggregation induced by abnormal N-glycosylation: Insights from Molecular dynamics simulation studies.

  2022cites this paper
• Amyloids on Membrane Interfaces: Implications for Neurodegeneration

  2022cites this paper
• The Role of Astrocytes in Synapse Loss in Alzheimer's Disease: A Systematic Review

  2022cites this paper
• Poloxamer-188 Exacerbates Brain Amyloidosis, Presynaptic Dystrophies, and Pathogenic Microglial Activation in 5XFAD Mice.

  2022cites this paper
• Contributive Role of Hyperglycemia and Hypoglycemia Towards the Development of Alzheimer’s Disease

  2022cites this paper
• Importin-Mediated Pathological Tau Nuclear Translocation Causes Disruption of the Nuclear Lamina, TDP-43 Mislocalization and Cell Death

  2022cites this paper
• Sleep-Wake Disorders in Alzheimer's Disease: A Review.

  2022cites this paper
• Current Drug Targets in Alzheimer's Associated Memory Impairment: A Comprehensive Review.

  2022cites this paper
• Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools

  2022cites this paper
• Sleep and Alzheimer: The Link.

  2022cites this paper
• Long-term mitochondrial stress induces early steps of Tau aggregation by increasing reactive oxygen species levels and affecting cellular proteostasis

  2022cites this paper
• Inflammation in obesity, diabetes, and related disorders.

  2022cites this paper
• Alzheimer’s Disease: From Pathogenesis to Mesenchymal Stem Cell Therapy – Bridging the Missing Link

  2022cites this paper
• Microtubules as Regulators of Neural Network Shape and Function: Focus on Excitability, Plasticity and Memory

  2022cites this paper
• Amyloid Cross-Seeding: Mechanism, Implication, and Inhibition

  2022cites this paper
• In silico designed microtubule-stabilizer drugs against tauopathy in Alzheimer’s disease

  2022cites this paper
• The Impaired Neurodevelopment of Human Neural Rosettes in HSV-1-Infected Early Brain Organoids

  2022cites this paper
• Studying Alzheimer’s Disease Using <i>Drosophila melanogaster</i> as a Powerful Tool

  2022cites this paper
• Alzheimer’s Disease: From Immune Homeostasis to Neuroinflammatory Condition

  2022cites this paper
• Interdisciplinary Approaches to Deal with Alzheimer’s Disease—From Bench to Bedside: What Feasible Options Do Already Exist Today?

  2022cites this paper